Literature DB >> 15964449

Blood vessels engineered from human cells.

Melissa Poh1, Matthew Boyer, Amy Solan, Shannon L M Dahl, Dawn Pedrotty, Soma S R Banik, J Andrew McKee, Rebecca Y Klinger, Christopher M Counter, Laura E Niklason.   

Abstract

Tissue engineering has made considerable progress in the past decade, but advances have stopped short of clinical application for most tissues. We postulated that an obstacle in engineering human tissues is the limited replicative capacity of adult somatic cells. To test this hypothesis, the effectiveness of telomerase expression to extend cellular lifespan was assessed in a model of human vascular tissue engineering. Telomerase expression in vascular cells isolated from elderly patients enabled the successful culture of engineered autologous blood vessels. Engineered vessels may one day provide a source of bypass conduit for patients with atherosclerotic disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964449     DOI: 10.1016/S0140-6736(05)66735-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  65 in total

Review 1.  Smooth muscle and other cell sources for human blood vessel engineering.

Authors:  Sumati Sundaram; Laura E Niklason
Journal:  Cells Tissues Organs       Date:  2011-10-25       Impact factor: 2.481

2.  Hair follicle-derived smooth muscle cells and small intestinal submucosa for engineering mechanically robust and vasoreactive vascular media.

Authors:  Hao-Fan Peng; Jin Yu Liu; Stelios T Andreadis; Daniel D Swartz
Journal:  Tissue Eng Part A       Date:  2011-01-16       Impact factor: 3.845

3.  Application of the cell sheet technique in tissue engineering.

Authors:  Guangnan Chen; Yiying Qi; Lie Niu; Tuoyu DI; Jinwei Zhong; Tingting Fang; Weiqi Yan
Journal:  Biomed Rep       Date:  2015-09-29

4.  Environmental parameters influence non-viral transfection of human mesenchymal stem cells for tissue engineering applications.

Authors:  William J King; Nicholas A Kouris; Siyoung Choi; Brenda M Ogle; William L Murphy
Journal:  Cell Tissue Res       Date:  2012-01-26       Impact factor: 5.249

Review 5.  Tissue-engineered vascular grafts for use in the treatment of congenital heart disease: from the bench to the clinic and back again.

Authors:  Joseph T Patterson; Thomas Gilliland; Mark W Maxfield; Spencer Church; Yuji Naito; Toshiharu Shinoka; Christopher K Breuer
Journal:  Regen Med       Date:  2012-05       Impact factor: 3.806

6.  Novel utilization of serum in tissue decellularization.

Authors:  Liqiong Gui; Stephen A Chan; Christopher K Breuer; Laura E Niklason
Journal:  Tissue Eng Part C Methods       Date:  2010-04       Impact factor: 3.056

Review 7.  Stem cell sources for vascular tissue engineering and regeneration.

Authors:  Vivek K Bajpai; Stelios T Andreadis
Journal:  Tissue Eng Part B Rev       Date:  2012-07-03       Impact factor: 6.389

8.  Application of induced pluripotent stem cells to model smooth muscle cell function in vascular diseases.

Authors:  HaYeun Ji; Hye Sung Kim; Hae-Won Kim; Kam W Leong
Journal:  Curr Opin Biomed Eng       Date:  2017-03-22

Review 9.  Cellular lifespan and regenerative medicine.

Authors:  Thomas Petersen; Laura Niklason
Journal:  Biomaterials       Date:  2007-05-25       Impact factor: 12.479

10.  Differentiation of bone marrow mesenchymal stem cells into the smooth muscle lineage by blocking ERK/MAPK signaling pathway.

Authors:  Kenichi Tamama; Chandan K Sen; Alan Wells
Journal:  Stem Cells Dev       Date:  2008-10       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.